Paper41340907
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effects of Single and Multiple Oral Doses of ABP-671 in Healthy and Hyperuricemic Subjects.
Gurwith M and 4 others. Drug Des Devel Ther, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effects of Single and Multiple Oral Doses of ABP-671 in Healthy and Hyperuricemic Subjects. Papers, record 41340907. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41340907
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effects of Single and Multiple Oral Doses of ABP-671 in Healthy and Hyperuricemic Subjects.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Food-Drug Interactions | Major topic |
| Hyperuricemia | Major topic |
| Humans | |
| Administration, Oral | |
| Male | |
| Adult | |
| Female | |
| Cross-Over Studies | |
| Middle Aged | |
| Dose-Response Relationship, Drug | |
| Healthy Volunteers | |
| Young Adult | |
| Double-Blind Method | |
| Uric Acid |
Source PubMed
References22
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32541923 | Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors. | Nat Rev Rheumatol | 2020 | https://conductscience.org/library/papers/32541923 | PubMed |
| 2 | 30334639 | Safety and efficacy of verinurad, a selective URAT1 inhibitor, for the treatment of patients with gout and/or asymptomatic hyperuricemia in the United States and Japan: Findings from two phase II trials. | Mod Rheumatol | 2019 | https://conductscience.org/library/papers/30334639 | PubMed |
| 3 | 30915866 | Safety and tolerability of available urate-lowering drugs: a critical review. | Expert Opin Drug Saf | 2019 | https://conductscience.org/library/papers/30915866 | PubMed |
| 4 | 34907116 | Update on gout management: what is old and what is new. | Curr Opin Rheumatol | 2022 | https://conductscience.org/library/papers/34907116 | PubMed |
| 5 | 26907620 | Stronger Uricosuric Effects of the Novel Selective URAT1 Inhibitor UR-1102 Lowered Plasma Urate in Tufted Capuchin Monkeys to a Greater Extent than Benzbromarone. | J Pharmacol Exp Ther | 2016 | https://conductscience.org/library/papers/26907620 | PubMed |
| 6 | 34035002 | EULAR recommendations for intra-articular therapies. | Ann Rheum Dis | 2021 | https://conductscience.org/library/papers/34035002 | PubMed |
| 7 | 32390306 | 2020 American College of Rheumatology Guideline for the Management of Gout. | Arthritis Rheumatol | 2020 | https://conductscience.org/library/papers/32390306 | PubMed |
| 8 | 34754317 | Recent Updates of Natural and Synthetic URAT1 Inhibitors and Novel Screening Methods. | Evid Based Complement Alternat Med | 2021 | https://conductscience.org/library/papers/34754317 | PubMed |
| 9 | 28744099 | Pharmacokinetics, pharmacodynamics, and tolerability of verinurad, a selective uric acid reabsorption inhibitor, in healthy adult male subjects. | Drug Des Devel Ther | 2017 | https://conductscience.org/library/papers/28744099 | PubMed |
| 10 | 33926357 | Dotinurad: a novel selective urate reabsorption inhibitor for the treatment of hyperuricemia and gout. | Expert Opin Pharmacother | 2021 | https://conductscience.org/library/papers/33926357 | PubMed |
| 11 | 29547895 | Gout: state of the art after a decade of developments. | Rheumatology (Oxford) | 2019 | https://conductscience.org/library/papers/29547895 | PubMed |
| 12 | 27380294 | Gout. | Ann Intern Med | 2016 | https://conductscience.org/library/papers/27380294 | PubMed |
| 13 | 31056705 | URC102, a potent and selective inhibitor of hURAT1, reduced serum uric acid in healthy volunteers. | Rheumatology (Oxford) | 2019 | https://conductscience.org/library/papers/31056705 | PubMed |
| 14 | 31889230 | Clinical pharmacological study of dotinurad administered to male and female elderly or young subjects. | Clin Exp Nephrol | 2020 | https://conductscience.org/library/papers/31889230 | PubMed |
| 15 | 34216576 | A brief review of urate transporter 1 (URAT1) inhibitors for the treatment of hyperuricemia and gout: Current therapeutic options and potential applications. | Eur J Pharmacol | 2021 | https://conductscience.org/library/papers/34216576 | PubMed |
| 16 | 25567367 | Population pharmacokinetics and exposure-uric acid analyses after single and multiple doses of ABT-639, a calcium channel blocker, in healthy volunteers. | AAPS J | 2015 | https://conductscience.org/library/papers/25567367 | PubMed |
| 17 | 34862252 | Pharmacokinetics, Mass Balance, and Metabolism of the Novel Urate Transporter 1 Inhibitor [14C]HR011303 in Humans: Metabolism Is Mediated Predominantly by UDP-Glucuronosyltransferase. | Drug Metab Dispos | 2022 | https://conductscience.org/library/papers/34862252 | PubMed |
| 18 | 27980008 | The Pharmacodynamics, Pharmacokinetics, and Safety of Arhalofenate in Combination with Febuxostat When Treating Hyperuricemia Associated with Gout. | J Rheumatol | 2017 | https://conductscience.org/library/papers/27980008 | PubMed |
| 19 | 27112094 | Gout. | Lancet | 2016 | https://conductscience.org/library/papers/27112094 | PubMed |
| 20 | 26170627 | Pharmacokinetics, pharmacodynamics, and safety of lesinurad, a selective uric acid reabsorption inhibitor, in healthy adult males. | Drug Des Devel Ther | 2015 | https://conductscience.org/library/papers/26170627 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SLC22A12 | 116085 | PubTator's text mining | https://conductscience.org/library/genes/116085 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41340907
GET https://conductscience.org/api/papers/v1/41340907/references?page=2